Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.9M Buy
61,485
+3,645
+6% +$427K 0.23% 88
2026
Q1
$6.96M Buy
57,840
+45,748
+378% +$5.28M 0.24% 88
2025
Q4
$1.27M Sell
12,092
-512
-4% -$48.1K 0.04% 329
2025
Q3
$1.06M Sell
12,604
-3,305
-21% -$272K 0.04% 362
2025
Q2
$1.26M Buy
15,909
+1,791
+13% +$142K 0.05% 302
2025
Q1
$1.27M Buy
14,118
+2,420
+21% +$226K 0.06% 285
2024
Q4
$1.16M Sell
11,698
-8,485
-42% -$875K 0.05% 310
2024
Q3
$2.29M Buy
20,183
+462
+2% +$54.9K 0.11% 197
2024
Q2
$2.44M Buy
19,721
+11,947
+154% +$1.54M 0.25% 83
2024
Q1
$1.03M Buy
7,774
+187
+2% +$23K 0.05% 290
2023
Q4
$827K Sell
7,587
-14,051
-65% -$1.46M 0.05% 268
2023
Q3
$2.23M Sell
21,638
-8,892
-29% -$958K 0.16% 128
2023
Q2
$3.52M Buy
+30,530
New +$3.47M 0.25% 79
2022
Q4
$4.2M Buy
37,820
+400
+1% +$40.9K 0.3% 59
2022
Q3
$3.22M Buy
37,420
+31,492
+531% +$2.81M 0.27% 66
2022
Q2
$540K Sell
5,928
-516
-8% -$45.7K 0.04% 307
2022
Q1
$529K Buy
6,444
+86
+1% +$6.78K 0.04% 324
2021
Q4
$487K Buy
+6,358
New +$506K 0.03% 370

Other funds holding MRK

CoreCap Advisors's MRK Position: Q2 2026 in Review

CoreCap Advisors increased its Merck (MRK) stake by 6.3% in Q2 2026, buying an estimated $427K and bringing the position to 61,485 shares worth $7.9M. The position accounts for 0.23% of the portfolio, ranked #88.

CoreCap Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CoreCap Advisors held 61,485 shares of Merck worth $7.9M as of Q2 2026.
  • CoreCap Advisors bought 3,645 Merck shares in Q2 2026, an estimated $427K.
  • Merck made up 0.23% of CoreCap Advisors's portfolio in Q2 2026, its #88 holding.
  • CoreCap Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.